Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
Sign Up to like & getrecommendations! Published in 2021 at "Digestive and Liver Disease"
DOI: 10.1016/j.dld.2020.12.120
Abstract: Background Patients receiving biologic therapies are at risk for viral infections. This study investigated the impact of the SARS-CoV-2 infection and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease (IBD) treated… read more here.
Keywords: biologic drugs; disease; treated biologic; prevalence sars ... See more keywords
AB0463 A review of the outcomes of women with rheumatoid arthritis (RA) treated with biologic agents attending the sheffield combined obstetrics and rheumatology clinic 2002 to 2013
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.2096
Abstract: Background Women with RA have increased risk of complications including preeclampsia, low birth weight babies and Caesarean sections compared with unaffected women.1 Higher levels of disease activity have a negative influence on birth weight.2 More… read more here.
Keywords: pregnancy; obstetrics; treated biologic; rheumatology ... See more keywords
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.202111-2496le
Abstract: 1. Papoutsi E, Giannakoulis VG, Xourgia E, Routsi C, Kotanidou A, Siempos II. Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of nonrandomized cohort… read more here.
Keywords: treated biologic; patients treated; vaccine response; response patients ... See more keywords